Alessio Amatu
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda(IT)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Genetic factors in colorectal cancer, HER2/EGFR in Cancer Research
Most-Cited Works
- → Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients(2015)1,079 cited
- → Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial(2016)993 cited
- → Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)(2017)807 cited
- → Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer(2013)658 cited
- → NTRK gene fusions as novel targets of cancer therapy across multiple tumour types(2016)589 cited
- → Adaptive mutability of colorectal cancers in response to targeted therapies(2019)437 cited
- → ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer(2017)323 cited
- → Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer(2019)294 cited
- → Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer(2014)268 cited
- → Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients(2015)259 cited